3 ETFs For the Coming Genomics Revolution

Key developments in the field of genomics—the study of the complete DNA of an organism—may make it possible to customize drug therapies, detect diseases, and engineer enzymes for improved health care outcomes. It's no wonder, then, that biotech and pharmaceuticals companies are